-
The health and care workforce in the Pandemic Agreement: championing equity and protecting collective capacity for future pandemics Lancet Global Health (IF 34.3) Pub Date : 2024-03-14 Veena Sriram, Leah Shipton, Julia Smith, Katrina Plamondon
-
Global brain health—the time to act is now Lancet Global Health (IF 34.3) Pub Date : 2024-03-14 Andrea S Winkler, Saksham Gupta, Vikram Patel, Arnold Bhebhe, Agnès Fleury, Camilla G Aukrust, Tarun Dua, Tamara M Welte, Sarbani Chakraborty, Kee B Park
-
No health without brain health Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 The Lancet Global Health
-
Aminoglycosides, deafness, and non-tuberculous mycobacteria Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Francis Drobniewski, Marcia Ashmi, Changchunzi He, Jamie Cheong, Anand Shah
-
Progress towards cultural safety in Indigenous cardiovascular health care and research Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Luke Burchill, Angela Dos Santos
-
High burden of typhoid disease in sub-Saharan Africa calls for urgent roll-out of typhoid conjugate vaccines Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Samuel Kariuki, Robert S Onsare
-
Outcomes of heart failure: gaps in knowledge and needs for action Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Yi Wu, Xi Li
-
Gout is a neglected non-communicable disease in the Pacific Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Cyrille Goarant, Shrish Acharya
-
Typhoid conjugate vaccines: a step towards typhoid control Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Mila Shakya, Andrew J Pollard
-
Excess vaccine-preventable disease mortality due to COVID-19 Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Kimberly M Thompson
-
Is intimate partner violence declining? It's still an open question – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Ning Ma, Yi Song, Zhihui Li
-
Strengthening health policy modelling in Africa Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 S M Thumbi, Jacquie Oliwa, Sheetal P Silal
-
The gout epidemic in French Polynesia: a modelling study of data from the Ma’i u’u epidemiological survey Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Prof Tristan Pascart MD, Kaja A Wasik PhD, Prof Cristian Preda PhD, Valérie Chune MD, Jérémie Torterat BSc, Nicolas Prud’homme BSc, Maryline Nassih BSN, Agathe Martin BSN, Julien Le Masson BSN, Vahinetua Rodière BSN, Sylvain Frogier BSN, Georges Canova BSN, Jean-Paul Pescheux BSN, Charles Shan Sei Fan MD, Charlotte Jauffret MD, Patrick Claeys BSN, Sarah LeBaron von Baeyer PhD, Stephane E Castel PhD
Gout is the most common cause of inflammatory arthritis worldwide, particularly in Pacific regions. We aimed to establish the prevalence of gout and hyperuricaemia in French Polynesia, their associations with dietary habits, their comorbidities, the prevalence of the allele, and current management of the disease. The Ma’i u’u survey was epidemiological, prospective, cross-sectional, and gout-focused
-
Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Florian Marks PhD, Justin Im PhD, Se Eun Park PhD, Gi Deok Pak MSc, Hyon Jin Jeon MPH, Lady Rosny Wandji Nana PharmD, Marie-France Phoba Master, Lisette Mbuyi-Kalonji Master, Ondari D Mogeni MPH, Biruk Yeshitela MSc, Ursula Panzner MPH, Ligia María Cruz Espinoza MD, Tigist Beyene MSc, Michael Owusu-Ansah MPH, Sampson Twumasi-Ankrah PhD, Melese Yeshambaw MSc, Ashenafi Alemu MSc, Oluwafemi J Adewusi
Typhoid Fever remains a major cause of morbidity and mortality in low-income settings. The Severe Typhoid in Africa programme was designed to address regional gaps in typhoid burden data and identify populations eligible for interventions using novel typhoid conjugate vaccines. A hybrid design, hospital-based prospective surveillance with population-based health-care utilisation surveys, was implemented
-
Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Michaela A Riddell PhD, Lisa M Vallely PhD, Alice Mengi MMedSci, Steven G Badman PhD, Prof Nicola Low MD, Handan Wand PhD, Prof John W Bolnga PhD, Delly Babona MMed, Prof Glen D L Mola FRCOG, Prof Virginia Wiseman PhD, Angela Kelly-Hanku PhD, Prof Caroline S E Homer PhD, Christopher Morgan PhD, Prof Stanley Luchters PhD, David M Whiley PhD, Prof Leanne J Robinson PhD, Lucy Au MSc, Irene Pukai-Gani
, and bacterial vaginosis have been associated with adverse maternal and perinatal outcomes, but there is conflicting evidence on the benefits of antenatal screening and treatment for these conditions. We aimed to determine the effect of antenatal point-of-care testing and immediate treatment of , , , and bacterial vaginosis on preterm birth, low birthweight, and other adverse maternal and perinatal
-
Does acute malnutrition in young children increase the risk of treatment failure following artemisinin-based combination therapy? A WWARN individual patient data meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 WWARN ACT Malaria and Malnutrition Study Group, Kasia Stepniewska, Richard Allan, Anupkumar R Anvikar, Thomas A Anyorigiya, Elizabeth A Ashley, Quique Bassat, Elisabeth Baudin, Anders Bjorkman, Maryline Bonnet, Caroline Boulton, Teun Bousema, Gwenaelle Carn, Verena I Carrara, Umberto D'Alessandro, Timothy ME Davis, Lise Denoeud-Ndam, Meghna Desai, Abdoulaye A Djimde, Grant Dorsey, Jean-François Etard
-
Impact with equity: EDCTP and equitable research partnerships Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Michael Makanga, Pauline Beattie, Dominika Jajkowicz, Thomas Nyirenda, Marcel Tanner, Catherine Hankins
-
Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Rabab Batool MS, Zoya Haq Qamar MBBS, Rehana Abdus Salam PhD, Mohammad Tahir Yousafzai PhD, Prof Per Ashorn MD, Prof Farah Naz Qamar FCPS
Typhoid is a serious public health threat in many low-income and middle-income countries. Several vaccines for typhoid have been recommended by WHO for typhoid prevention in endemic countries. This study aimed to review the efficacy of typhoid vaccines against culture-confirmed serovar Typhi. We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and Embase for studies published in
-
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Hua Wang MD, Yingying Li MD, Ke Chai MD, Zheng Long MPH, Zhikai Yang MD, Minghui Du MD, Prof Shengfeng Wang PhD, Prof Siyan Zhan PhD, Yujia Liu MD, Yuhao Wan MD, Prof Fang Wang MD, Prof Peng Yin PhD, Prof Weimin Li MD, Prof Yuhua Liao MD, Prof Yugang Dong MD, Prof Xinli Li MD, Prof Jingmin Zhou MD, Prof Kai-Hang Yiu MD PhD, Prof Maigeng Zhou PhD, Prof Yong Huo MD, Prof Jiefu Yang MD
China has the largest burden of heart failure worldwide. However, large-scale studies on heart failure mortality are scarce. We aimed to investigate mortality and identify risk factors for mortality among patients with heart failure in China. This prospective cohort study used data from the China Cardiovascular Association (CCA) Database-Heart Failure Centre Registry, which were linked to the National
-
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Anna-Maria Hartner MSc, Xiang Li PhD, Susy Echeverria-Londono PhD, Jeremy Roth PhD, Kaja Abbas PhD, Megan Auzenbergs PhD, Margaret J de Villiers PhD, Prof Matthew J Ferrari PhD, Keith Fraser PhD, Han Fu PhD, Prof Timothy Hallett PhD, Wes Hinsley PhD, Prof Mark Jit PhD, Andromachi Karachaliou PhD, Sean M Moore PhD, Shevanthi Nayagam MD, Timos Papadopoulos PhD, T Alex Perkins PhD, Allison Portnoy PhD
There have been declines in global immunisation coverage due to the COVID-19 pandemic. Recovery has begun but is geographically variable. This disruption has led to under-immunised cohorts and interrupted progress in reducing vaccine-preventable disease burden. There have, so far, been few studies of the effects of coverage disruption on vaccine effects. We aimed to quantify the effects of vaccine-coverage
-
Effects of a culturally informed model of care for Aboriginal and Torres Strait Islander patients with acute coronary syndrome in a tertiary hospital in Australia: a pre-post, quasi-experimental, interventional study Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Danielle L Harrop MBBS, Vivian Bryce MPH, Tanya Kitchener, Sean Grugan MPH, Sonia Renouf, Scott Mitchell BPharm, Gregory Hasking PhD, Debra Pauza GradCert, Gregory Richards BASc, Arnold C T Ng PhD, William Y S Wang PhD
Aboriginal and Torres Strait Islander (Indigenous) peoples with cardiac disease in Australia have worse outcomes than non-Indigenous people with cardiac disease. We hypothesised that the implementation of a culturally informed model of care for Indigenous patients hospitalised with acute coronary syndrome (ACS) would improve their clinical outcomes. For this pre-post, quasi-experimental, interventional
-
Is intimate partner violence declining? It's still an open question Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Kathryn M Yount, Lu Gram, Amber Peterman
-
National plans and awareness campaigns as priorities for achieving global brain health Lancet Global Health (IF 34.3) Pub Date : 2024-03-12 Sebastian F Winter MD, Donna Walsh BA, Coriene Catsman-Berrevoets MD, Prof Valery Feigin PhD, Frédéric Destrebecq MA, Prof Suzanne L Dickson PhD, Matilde Leonardi MD, Volker Hoemberg MD, Prof Cristina Tassorelli MD, Maria Teresa Ferretti PhD, Anna Dé MSc, Antonella Santuccione Chadha MD, Chris Lynch BA, Sophia Bakhtadze MD, Deanna Saylor MD, Soonmyung Hwang BS, Kevin Rostasy MD, Prof Benzi M Kluger
Neurological conditions are the leading cause of death and disability combined. This public health crisis has become a global priority with the introduction of WHO's (IGAP). 18 months after this plan was adopted, global neurology stakeholders, including representatives of the OneNeurology Partnership (a consortium uniting global neurology organisations), take stock and advocate for urgent acceleration
-
Onchocerciasis elimination in sub-Saharan Africa requires alternative strategies Lancet Global Health (IF 34.3) Pub Date : 2024-03-11 Alfred K Njamnshi, Wepnyu Y Njamnshi, Joseph N Siewe Fodjo
-
Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-03-11 Nyamai Mutono PhD, Prof Maria-Gloria Basáñez PhD, Ananthu James PhD, Wilma A Stolk PhD, Anita Makori BSc, Teresia Njoki Kimani MSc, Prof T Déirdre Hollingsworth PhD, Andreia Vasconcelos PhD, Matthew A Dixon PhD, Prof Sake J de Vlas PhD, Prof S M Thumbi PhD
WHO has proposed elimination of transmission of onchocerciasis (river blindness) by 2030. More than 99% of cases of onchocerciasis are in sub-Saharan Africa. Vector control and mass drug administration of ivermectin have been the main interventions for many years, with varying success. We aimed to identify factors associated with elimination of onchocerciasis transmission in sub-Saharan Africa. For
-
Delivering health for all: the critical role of gender-responsive health systems Lancet Global Health (IF 34.3) Pub Date : 2024-03-07 Angeli Achrekar, Svetlana Akselrod, Helen Clark, Gabriela Cuevas Barron, Michael Charles, Katie Dain, Roopa Dhatt, Maliha Khan, Justin Koonin, Ilayda Oankoy, Swostika Thapaliya, Chantal Umuhoza
-
The value of longitudinal qualitative approaches in vaccination pilot studies Lancet Global Health (IF 34.3) Pub Date : 2024-02-28 Violet Naanyu
-
Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective Lancet Global Health (IF 34.3) Pub Date : 2024-02-28 Jenny Hill PhD, Teresa Bange MSc, Jenna Hoyt MSc, Simon Kariuki PhD, Mohamed F Jalloh PhD, Prof Jayne Webster PhD, George Okello PhD
Malaria accounts for over half a million child deaths annually. WHO recommends RTS,S/AS01 to prevent malaria in children living in moderate-to-high malaria transmission regions. We conducted a qualitative longitudinal study to investigate the contextual and dynamic factors shaping vaccine delivery and uptake during a pilot introduction in western Kenya. The study was conducted between Oct 3, 2019,
-
Cost-effectiveness of task-shifting in resource-constrained settings Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Mary Lou Chatterton, Yared Belete Belay
-
Advancing mental health service delivery in low-resource settings Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Dong (Roman) Xu, George Chikondi Samu, Jiangyun Chen
-
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Juan Yanguela MSc, Prof Brian W Pence PhD, Michael Udedi PhD, Jonathan Chiwanda Banda PhD, Kazione Kulisewa MMed, Chifundo C Zimba PhD, Jullita K Malava MA, Christopher Akiba PhD, Josée M Dussault PhD, Abigail M Morrison MPH, Steve Mphonda BA, Prof Mina C Hosseinipour MD, Prof Bradley N Gaynes MD, Prof Stephanie B Wheeler PhD
Depression is a major contributor to morbidity and mortality in sub-Saharan Africa. Due to low system capacity, three in four patients with depression in sub-Saharan Africa go untreated. Despite this, little attention has been paid to the cost-effectiveness of implementation strategies to scale up evidence-based depression treatment in the region. In this study, we investigate the cost-effectiveness
-
Two implementation strategies to support the integration of depression screening and treatment into hypertension and diabetes care in Malawi (SHARP): parallel, cluster-randomised, controlled, implementation trial Lancet Global Health (IF 34.3) Pub Date : 2024-02-23 Prof Brian W Pence PhD, Prof Bradley N Gaynes MD, Michael Udedi PhD, Kazione Kulisewa MMed, Chifundo C Zimba PhD, Christopher F Akiba PhD, Josée M Dussault PhD, Harriet Akello BSc, Jullita K Malava MPH, Amelia Crampin MBChB, Ying Zhang PhD, Prof John S Preisser PhD, Prof Stephanie M DeLong PhD, Prof Mina C Hosseinipour MD
Although evidence-based treatments for depression in low-resource settings are established, implementation strategies to scale up these treatments remain poorly defined. We aimed to compare two implementation strategies in achieving high-quality integration of depression care into chronic medical care and improving mental health outcomes in patients with hypertension and diabetes. We conducted a parallel
-
Ending the neglect of paediatric, maternal, and congenital mpox Lancet Global Health (IF 34.3) Pub Date : 2024-02-21 Nadia Adjoa Sam-Agudu, Dimie Ogoina
-
Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-02-21 Nuria Sanchez Clemente PhD, Charlotte Coles MSc, Enny S Paixao PhD, Prof Elizabeth B Brickley PhD, Elizabeth Whittaker PhD, Tobias Alfven PhD, Stephen Rulisa PhD, Nelson Agudelo Higuita MD, Paul Torpiano MD, Priyesh Agravat MBBS, Emma V Thorley MB BChir, Simon B Drysdale PhD, Prof Kirsty Le Doare PhD, Prof Jean-Jacques Muyembe Tamfum PhD
Although mpox has been detected in paediatric populations in central and west Africa for decades, evidence synthesis on paediatric, maternal, and congenital mpox, and the use of vaccines and therapeutics in these groups, is lacking. A systematic review is therefore indicated to set the research agenda. We conducted a systematic review and meta-analysis, searching articles in Embase, Global Health,
-
An indicator framework for the monitoring and evaluation of event-based surveillance systems Lancet Global Health (IF 34.3) Pub Date : 2024-02-13 Adam W Crawley MPH, Kyeng Mercy MPH, Sabrina Shivji MSc, Hannah Lofgren MPH, Daniella Trowbridge MPH, Christine Manthey PhD, Yenew Kebede Tebeje MD, Alexey Wil Clara MD, Kimberly Landry MPH, Stephanie J Salyer DVM
Event-based surveillance (EBS) systems have been implemented globally to support early warning surveillance across human, animal, and environmental health in diverse settings, including at the community level, within health facilities, at border points of entry, and through media monitoring of internet-based sources. EBS systems should be evaluated periodically to ensure that they meet the objectives
-
Correction to Lancet Glob Health 2023; 11: e1978–85 Lancet Global Health (IF 34.3) Pub Date : 2024-02-09
-
Correction to Lancet Glob Health 2023; 11: e1713–24 Lancet Global Health (IF 34.3) Pub Date : 2024-02-09
-
Compounding challenges for Syrian refugees in Türkiye in the wake of the earthquake Lancet Global Health (IF 34.3) Pub Date : 2024-02-07 Rasha Kaloti, Jasmin Lilian Diab, Munzer Alkhalil, Diana Rayes, Aula Abbara
-
Unveiling the crisis of the double burden of malnutrition Lancet Global Health (IF 34.3) Pub Date : 2024-01-29 Biniyam Sahiledengle, Lillian Mwanri
Abstract not available
-
The effect of nutrition-specific and nutrition-sensitive interventions on the double burden of malnutrition in low-income and middle-income countries: a systematic review Lancet Global Health (IF 34.3) Pub Date : 2024-01-29 Nora A Escher, Giovanna C Andrade, Suparna Ghosh-Jerath, Christopher Millett, Paraskevi Seferidi
Background Low-income and middle-income countries (LMICs) experiencing nutrition transition face an increasing double burden of malnutrition (DBM). WHO has urged the identification of risks and opportunities in nutrition interventions to mitigate the DBM, but robust evidence is missing. This review summarises the effect of nutrition-specific and nutrition-sensitive interventions on undernutrition and
-
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance Lancet Global Health (IF 34.3) Pub Date : 2024-01-23 Marc Mendelson, Ramanan Laxminarayan, Direk Limmathurotsakul, Samuel Kariuki, Martha Gyansa-Lutterodt, Esmita Charani, Sanjeev Singh, Kamini Walia, Ana C Gales, Mirfin Mpundu
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions
-
Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2024-01-22 Jenny L Schnyder, Hanna K de Jong, Bache E Bache, Frieder Schaumburg, Martin P Grobusch
Background Long-term immunity following yellow fever vaccination remains controversial. We aimed to summarise the literature regarding the long-term protection (≥10 years) conveyed by a single dose of yellow fever vaccination. Methods In this systematic review and meta-analysis, we searched 11 databases from database inception to Aug 24, 2023. We included cohort and cross-sectional studies reporting
-
The life-long protective immunity of yellow fever vaccination: time to review? Lancet Global Health (IF 34.3) Pub Date : 2024-01-22 Aitana Juan-Giner, Joachim Hombach
Abstract not available
-
The urgency of identifying global priorities for hearing loss prevention Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Alessandra Giannella Samelli, Carla Gentile Matas
Abstract not available
-
Latent viral infections as neglected risk factors for long COVID Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Amir Abdoli, Ali Taghipour, Mirza Ali Mofazzal Jahromi, Fatemeh Eftekharian, Reza Sahraei, Mohammad Sadegh Sanie
Abstract not available
-
Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Kavita Prasad, Ethan D Borre, Lauren K Dillard, Austin Ayer, Carolina Der, Kathleen E Bainbridge, Catherine M McMahon, Debara L Tucci, Blake S Wilson, Gillian D Sanders Schmidler, James Saunders
Background Hearing loss affects approximately 1·6 billion individuals worldwide. Many cases are preventable. We aimed to estimate the annual number of new hearing loss cases that could be attributed to meningitis, otitis media, congenital rubella syndrome, cytomegalovirus, and ototoxic medications, specifically aminoglycosides, platinum-based chemotherapeutics, and antimalarials. Methods We used a
-
Noma: neglected no more? Lancet Global Health (IF 34.3) Pub Date : 2024-01-18
Abstract not available
-
Triage test to diagnose presumptive pulmonary tuberculosis Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Renu Verma, Kalaiarasan Ellappan, Karen E Kempsell, Noyal Mariya Joseph
Abstract not available
-
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Annelies Wilder-Smith
Abstract not available
-
Priorities to reduce the burden of hypertension in Africa through ACHIEVE Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Paul Olowoyo, Prebo Barango, Andrew Moran, Bryan Williams, Paul K Whelton, Mayowa Owolabi
Abstract not available
-
Malaria guidelines fall short in diagnosing acute kidney injury Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Anthony Batte, Valerie A Luyckx, Terrie E Taylor, Andrea L Conroy
Abstract not available
-
Latent viral infections as neglected risk factors for long COVID – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Sophie Alice Müller, Lynda Isaaka, Rebekka Mumm, Christa Scheidt-Nave, Katharina Heldt, Angela Schuster, Mohammed Abdulaziz, Charbel El-Bcheraoui, Johanna Hanefeld, Ambrose Agweyu
Abstract not available
-
Dengue vector habitats in Ouagadougou, Burkina Faso, 2020: an unintended consequence of the installation of public handwashing stations for COVID-19 prevention Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Wendegoudi M Ouédraogo, Nicolas Zanré, Noah H Rose, Julien Z B Zahouli, Luc S Djogbenou, Mafalda Viana, Hirotaka Kanuka, David Weetman, Philip J McCall, Athanase Badolo
Abstract not available
-
Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Ankur Gupta-Wright, Huy Ha, Shima Abdulgadar, Rebecca Crowder, Jerusha Emmanuel, Job Mukwatamundu, Danaida Marcelo, Patrick P J Phillips, Devasahayam Jesudas Christopher, Nguyen Viet Nhung, Grant Theron, Charles Yu, Payam Nahid, Adithya Cattamanchi, William Worodria, Claudia M Denkinger
Background Non-sputum-based triage tests for tuberculosis are a priority for ending tuberculosis. We aimed to evaluate the diagnostic accuracy of the late-prototype Xpert MTB Host Response (Xpert HR) blood-based assay. Methods We conducted a prospective diagnostic accuracy study among outpatients with presumed tuberculosis in outpatient clinics in Viet Nam, India, the Philippines, Uganda, and South
-
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Rui Zhao, Christopher K Fairley, Alex R Cook, Nittaya Phanuphak, Shiyi He, Warittha Tieosapjaroen, Eric P F Chow, Tiffany R Phillips, Rayner Kay Jin Tan, Yuhang Wei, Mingwang Shen, Guihua Zhuang, Jason J Ong, Lei Zhang
Background Men who have sex with men (MSM) in the Asia-Pacific region have a disproportionately high burden of HIV infection compared with the general population. Although pre-exposure prophylaxis (PrEP) for HIV is highly effective at preventing new HIV infections, the cost-effectiveness of PrEP for MSM in different countries in the Asia-Pacific region with varying PrEP coverage and HIV testing frequencies
-
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Vianney Tricou, Delia Yu, Humberto Reynales, Shibadas Biswal, Xavier Saez-Llorens, Chukiat Sirivichayakul, Pio Lopez, Charissa Borja-Tabora, Lulu Bravo, Pope Kosalaraksa, Luis Martinez Vargas, Maria Theresa Alera, Luis Rivera, Veerachai Watanaveeradej, Reynaldo Dietze, LakKumar Fernando, V Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D Fernando, Dulanie Gunasekera, Derek Wallace
Background About half of the world's population lives in dengue-endemic areas. We aimed to evaluate the long-term efficacy and safety of two doses of the tetravalent dengue vaccine TAK-003 in preventing symptomatic dengue disease of any severity and due to any dengue virus (DENV) serotypes in children and adolescents. Methods In this ongoing double-blind, randomised, placebo-controlled trial, we enrolled
-
Racial disparities in breast cancer survival after treatment initiation in Brazil: a nationwide cohort study Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Lívia Lovato Pires Lemos, Mirian Carvalho Souza, Augusto Afonso Guerra, Thais Piazza, Rodrigo Moura Araújo, Mariangela Leal Cherchiglia
Background Breast cancer is a public health priority in Brazil and ensuring equity in health care is one of the cancer control plan goals. Our aim was to present the first assessment on the influence of race or skin colour on breast cancer survival at the national level. Methods In this nationwide cohort study, data on women who initiated treatment for breast cancer in the public health-care system
-
Correction to Lancet Glob Health 2022; 10: 1715–43 Lancet Global Health (IF 34.3) Pub Date : 2024-01-17
Abstract not available
-
Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a model-based cost-effectiveness analysis of a pragmatic, cluster-randomised trial in seven low-income and middle-income countries Lancet Global Health (IF 34.3) Pub Date : 2024-01-18
Background Surgical site infection (SSI) is a major burden on patients and health systems. This study assessed the cost-effectiveness of routine change of sterile gloves and instruments before abdominal wall closure to prevent SSI. Methods A decision-analytic model was built to estimate average costs and outcomes of changing gloves and instruments before abdominal wall closure compared with current
-
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region Lancet Global Health (IF 34.3) Pub Date : 2024-01-18 Benjamin R Bavinton, Nila J Dharan
Abstract not available